Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Daniel Shao-Weng Tan, James Chih-Hsin Yang, Natasha B. Leighl, Gregory J. Riely, Lecia V. Sequist, Enriqueta Felip, Takashi Seto, Juergen Wolf, Susan Elizabeth Moody, Kenneth Adams, Shu-Fang Hsu Schmitz, Eugene Y. Tan, Dong-Wan Kim | ||||||||||||
Title | Updated results of a phase 1 study of EGF816, a third-generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/162578-176 | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 9044) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|